Empowering Biologic Breakthroughs: Transforming Tomorrow’s Healthcare Landscape Through Microbial-Based Development and Manufacturing

Rebekka Wuester

March 28, 2024

1 Min Read


Microbial expression systems are crucial in developing innovative medicines and expanding development pipelines due to the broad range of molecule formats that can be obtained using this technology. However, this approach can be challenging as it requires a variety of manufacturing processes to handle these diverse molecule formats. This is where collaboration with an experienced organization comes into play. Boehringer Ingelheim, known for its proficiency in this technical domain, has a proven track record with 19 commercial microbial products and successful audits and regulatory compliance. The company's commitment to quality and flexibility in implementing production processes make it a reliable partner. Its technology-platform neutrality also simplifies technology and process transfers.

Fill out the form below to read the full report.

You May Also Like